⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma

Official Title: A Randomized, Open Label, Multicenter Phase 2/3 Study to Evaluate the Efficacy and Safety of Rogaratinib (BAY1163877) Compared to Chemotherapy in Patients With FGFR-positive Locally Advanced or Metastatic Urothelial Carcinoma Who Have Received Prior Platinum-containing Chemotherapy

Study ID: NCT03410693

Study Description

Brief Summary: This is a randomized, open-label, multicenter Phase 2/3 study to evaluate the efficacy and safety of rogaratinib (BAY 1163877) compared to chemotherapy in patients with FGFR-positive locally advanced or metastatic urothelial carcinoma who have received prior platinum-containing chemotherapy. The primary objective is to demonstrate the superiority of rogaratinib over chemotherapy in terms of objective response rate (before: overall survivial) of urothelial carcinoma patients with FGFR positive tumors. At randomization, patients will have locally advanced or metastatic urothelial carcinoma and have received at least one prior platinum-containing chemotherapy regimen. Only patients with FGFR1 or 3 positive tumors can be randomized into the study. Archival tumor tissue is adequate for testing of FGFR1 and 3 mRNA expressions, which will be determined centrally using an RNA in situ hybridization (RNA-ISH) test. Approximately 42 % of UC patients with locally advanced or metastatic UC are identified as FGFR-positive by the RNA-ISH cut-off applied.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Alaska Clinical Research Center, LLC, Anchorage, Alaska, United States

University of Arizona Cancer Center, Tucson, Arizona, United States

University of Southern California, Los Angeles, California, United States

UC Davis Comprehensive Cancer Center, Sacramento, California, United States

Sansum Clinic, Santa Barbara, California, United States

Rocky Mountain Cancer Centers, Littleton, Colorado, United States

UF Cancer Center at Orlando Health, Orlando, Florida, United States

University of Kansas Medical Center, Westwood, Kansas, United States

Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States

Compass Oncology, Tigard, Oregon, United States

University of Pittsburgh, Pittsburgh, Pennsylvania, United States

Bon Secours St. Francis Hospital, Greenville, South Carolina, United States

Texas Oncology-Denton South, Denton, Texas, United States

Houston Methodist Hospital, Houston, Texas, United States

Virginia Mason Medical Center, Seattle, Washington, United States

Summit Cancer Center, Spokane, Washington, United States

Mid North Coast Cancer Institute, Coffs Harbour, New South Wales, Australia

Northern Cancer Institute, St Leonards, New South Wales, Australia

Macquarie University Hospital, Sydney, New South Wales, Australia

Riverina Cancer Care Centre, Wagga Wagga, New South Wales, Australia

Sydney Adventist Hospital, Wahroonga, New South Wales, Australia

Pindara Private Hospital, Benowa, Queensland, Australia

Monash Medical Centre, Clayton, Victoria, Australia

Landesklinikum Krems, Krems, , Austria

Krankenhaus der Barmherzigen Brüder, Wien, , Austria

Universitätsklinikum AKH Wien, Wien, , Austria

Klinik Ottakring - Wilhelminenspital, Wien, , Austria

UZ Gent, Gent, , Belgium

UZ Leuven Gasthuisberg, Leuven, , Belgium

Clinique Saint-Pierre, Ottignies, , Belgium

Princess Margaret Hospital-University Health Network, Toronto, Ontario, Canada

Sir Mortimer B. Davis Jewish General Hospital, Montreal, Quebec, Canada

Ottawa Hospital-General Campus, Ottawa, , Canada

FuJian Medical University Union Hospital, Fuzhou, Fujian, China

Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China

Hubei Cancer Hospital, Wuhan, Hubei, China

NJ Drum Tower Hospital, the Affil Hos of NJ Univ Med School, Nanjing, Jiangsu, China

Jiangsu Cancer Hospital, Nanjing, Jiangsu, China

Liaoning Cancer Hospital and Institute, Shengyang, Liaoning, China

Fifth Medical Center, General Hospital of the Chinese People, Beijing, , China

First Affiliated Hospital of Guangzhou Medical University, Guangzhou, , China

Fudan University Shanghai Cancer Center, Shanghai, , China

Huadong Hospital, Affiliated to Fudan University, Shanghai, , China

Fakultni nemocnice Ostrava, Ostrava, , Czechia

Fakultni nemocnice Kralovske Vinohrady, Praha 10, , Czechia

Fakultni Thomayerova Nemocnice, Praha 4 - Krc, , Czechia

Bata Hospital, Zlin, , Czechia

Aarhus Universitetshospital, Skejby, Aarhus N, , Denmark

Herlev Hospital - Oncology Research Dept., Herlev, , Denmark

Rigshospitalet, København, , Denmark

Docrates Klinikka, Helsinki, , Finland

Hopital Jean Minjoz, Besancon, , France

Hôpital Saint André - Bordeaux, Bordeaux, , France

Centre de Lutte Contre le Cancer François Baclesse, Caen Cedex 5, , France

Centre Jean Perrin, Clermont Ferrand Cedex 1, , France

Centre Oscar Lambret - Lille, Lille Cedex, , France

Centre Léon Bérard, Lyon Cedex, , France

Institut Paoli-Calmettes - Marseille, Marseille, , France

Cochin - Paris, Paris, , France

Hôpital d'Instruction des Armées Begin, Saint Mande, , France

Clinique Saint Anne, Strasbourg, , France

Centre Médico-Chirurgical Foch, Suresnes, , France

Eberhard-Karls-Universität Tübingen, Tübingen, Baden-Württemberg, Germany

Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Nordrhein-Westfalen, Germany

Universitätsmedizin der Johannes Gutenberg Universität Mainz, Mainz, Rheinland-Pfalz, Germany

Prince of Wales Hospital Hong Kong, Shatin, , Hong Kong

MH Egeszsegugyi Kozpont, Budapest, , Hungary

Orszagos Onkologiai Intezet, Budapest, , Hungary

Pecsi Tudomanyegyetem Klinikai Kozpont, Pecs, , Hungary

Cork University Hospital, Cork, , Ireland

AMNCH, Dublin, , Ireland

Rambam Health Corporation, Haifa, , Israel

Hadassah Hebrew University Hospital Ein Kerem, Jerusalem, , Israel

Meir Medical Center, Kfar Saba, , Israel

Clalit Health Services Rabin Medical Center-Beilinson Campus, Petah Tikva, , Israel

Chaim Sheba Medical Center, Ramat Gan, , Israel

IRST Istituto Scientifico Romagnolo per studio e cura tumori, Forlì Cesena, Emilia-Romagna, Italy

AUSL Modena, Modena, Emilia-Romagna, Italy

A.O.U. di Modena - Policlinico, Modena, Emilia-Romagna, Italy

A.O. San Camillo-Forlanini, Roma, Lazio, Italy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Lazio, Italy

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Lombardia, Italy

IRCCS Istituto Europeo di Oncologia s.r.l. (IEO), Milano, Lombardia, Italy

ASST Grande Ospedale Metropolitano Niguarda, Milano, Lombardia, Italy

A.O.U. San Luigi Gonzaga, Torino, Piemonte, Italy

A.O.U. Pisana, Pisa, Toscana, Italy

A.O.U.I. Verona, Verona, Veneto, Italy

Nagoya University Hospital, Nagoya, Aichi, Japan

Hirosaki University Hospital, Hirosaki, Aomori, Japan

Gunma University Hospital, Maebashi, Gunma, Japan

Gunma Prefectural Cancer Center, Ota, Gunma, Japan

Sapporo Medical University Hospital, Sapporo, Hokkaido, Japan

Hokkaido University Hospital, Sapporo, Hokkaido, Japan

Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan

University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan

Iwate Medical University Hospital, Morioka, Iwate, Japan

Yokohama City University Hospital, Yokohama, Kanagawa, Japan

Kindai University Hospital, Osakasayama, Osaka, Japan

Saitama Medical University International Medical Center, Hidaka, Saitama, Japan

Nippon Medical School Hospital, Bunkyo-ku, Tokyo, Japan

National Cancer Center Hospital, Chuo-ku, Tokyo, Japan

The Cancer Institute Hospital of JFCR, Koto-ku, Tokyo, Japan

Keio University Hospital, Shinjuku-ku, Tokyo, Japan

Akita University Hospital, Akita, , Japan

Kyushu University Hospital, Fukuoka, , Japan

Hiroshima City Hiroshima Citizens Hospital, Hiroshima, , Japan

Kumamoto University Hospital, Kumamoto, , Japan

Niigata University Medical and Dental Hospital, Niigata, , Japan

Osaka International Cancer Institute, Osaka, , Japan

Toyama University Hospital, Toyama, , Japan

National Cancer Center, Goyang-si, Gyeonggido, Korea, Republic of

Severance Hospital, Yonsei University Health System, Seoul, , Korea, Republic of

Asan Medical Center, Seoul, , Korea, Republic of

Samsung Medical Center, Seoul, , Korea, Republic of

Nederlands Kanker Instituut, Amsterdam, , Netherlands

Erasmus Medisch Centrum, Rotterdam, , Netherlands

Centrum Onkologii im. Prof. Franciszka Lukaszczyka, Bydgoszcz, , Poland

Swietokrzyskie Centrum Onkologii, Kielce, , Poland

Przychodnia Lekarska KOMED, Konin, , Poland

Samodzielny Publiczny Zespol Gruzlicy i Chorob Pluc, Olsztyn, , Poland

Szpital Kliniczny Przemienienia Panskiego, Poznan, , Poland

Uniwersytecki Szpital Kliniczny UM we Wroclawiu, Wroclaw, , Poland

Hospital Beatriz Angelo, Loures, Lisboa, Portugal

IPO Coimbra, Coimbra, , Portugal

Hospital CUF Infante Santo, Lisboa, , Portugal

CHULN - Hospital Santa Maria, Lisboa, , Portugal

Centro Hospitalar Universitario do Porto, Porto, , Portugal

Krasnoyarsk Regional Clinical Oncology Dispensary, Krasnoyarsk, , Russian Federation

Moscow Scient. Res. Institute of Oncology n.a P.A. Hertzen, Moscow, , Russian Federation

Volga District Med Center FMBA, Nizhny Novgorod, , Russian Federation

Clinical Oncological Dispensary of Omsk Region, Omsk, , Russian Federation

Bashkir State Medical University, Ufa, , Russian Federation

National University Hospital, Singapore, , Singapore

National Cancer Center Singapore, Singapore, , Singapore

Narodny onkologicky ustav, Bratislava, , Slovakia

UROEXAM, spol. s r.o., Nitra, , Slovakia

POKO Poprad s.r.o., Poprad, , Slovakia

Institut Català d'Oncologia Badalona, Badalona, Barcelona, Spain

Institut Català d'Oncologia Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain

Hospital Universitari Son Espases, Palma de Mallorca, Illes Baleares, Spain

Hospital del Mar, Barcelona, , Spain

Ciutat Sanitària i Universitaria de la Vall d'Hebron, Barcelona, , Spain

Hospital San Pedro de Alcántara, Cáceres, , Spain

Hospital Reina Sofía, Córdoba, , Spain

Hospital Ramón y Cajal, Madrid, , Spain

Hospital Universitario 12 de Octubre, Madrid, , Spain

Hospital Virgen de la Victoria, Málaga, , Spain

Instituto Valenciano de Oncología, Valencia, , Spain

Hospital General Universitario de Valencia, Valencia, , Spain

Södersjukhuset, Stockholm, , Sweden

Karolinska Institutet, Stockholm, , Sweden

Universitätsspital Basel, Basel, Basel-Stadt, Switzerland

Kantonsspital Graubünden, Chur, Graubünden, Switzerland

Kantonsspital St. Gallen, St. Gallen, Sankt Gallen, Switzerland

Taichung Veterans General Hospital, Taichung, , Taiwan

National Cheng Kung University Hospital, Tainan, , Taiwan

National Taiwan University Hospital, Taipei, , Taiwan

Taipei Veterans General Hospital, Taipei, , Taiwan

Chang Gung Memorial Hospital at Linkou, Taoyuan, , Taiwan

Clatterbridge Centre for Oncology, Bebington, Merseyside, United Kingdom

Royal Marsden Hospital (London), London, , United Kingdom

Contact Details

Name: Bayer Study Director

Affiliation: Bayer

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: